Targeting the PDGF-B/PDGFR-β Interface with Destruxin A5 to Selectively Block PDGF-BB/PDGFR-ββ Signaling and Attenuate Liver Fibrosis

@article{Wang2016TargetingTP,
  title={Targeting the PDGF-B/PDGFR-$\beta$ Interface with Destruxin A5 to Selectively Block PDGF-BB/PDGFR-$\beta$$\beta$ Signaling and Attenuate Liver Fibrosis},
  author={Xing Qi Wang and Xuefeng Wu and Ai Hua Zhang and Shiyu Wang and Chunhui Hu and Wei Chen and Yan Shen and Renxiang Tan and Yang Sun and Qiang Xu},
  journal={EBioMedicine},
  year={2016},
  volume={7},
  pages={146 - 156}
}

Figures from this paper

PDGFs and their receptors.
Structural insights into the modulation of PDGF/PDGFR-β complexation by hyaluronan derivatives
TLDR
The results found open the path for considering HA4 derivatives as potential candidates to be exploited for modulation of the PDGF/PDGFR-β signaling system in angiogenesis and related disease conditions.
Involvement of PDGF ligands and receptors in tumorigenesis
TLDR
Over-activity of PDGF signaling is associated with malignancies and other diseases characterized by excessive cell proliferation, such as fibrotic conditions and atherosclerosis, and inhibitors ofPDGF signaling may be of clinical usefulness in the treatment of certain tumors.
Thymosinβ4 alleviates cholestatic liver fibrosis in mice through downregulating PDGF/PDGFR and TGFβ/Smad pathways.
  • Cai Chen, Xiankui Li, Lei Wang
  • Medicine, Biology
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2019
Involvement of platelet‐derived growth factor ligands and receptors in tumorigenesis
TLDR
Overactivity of PDGF signalling is associated with malignancies and other diseases characterized by excessive cell proliferation, such as fibrotic conditions and atherosclerosis, and inhibitors ofPDGF signalling may be of clinical usefulness in the treatment of certain tumours.
Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis
TLDR
It is shown that focal-adhesion-kinse (FAK) plays a key role in promoting hepatic stellate cells (HSCs) activation in vitro and liver fibrosis progression in vivo and FAK signaling pathway could be a potential target for Liver fibrosis.
PDGF in organ fibrosis.
Therapy that Targets Growth Factor Receptors: Novel Approach for Liver Cirrhosis Treatment
TLDR
This chapter represents the evidences of the efficacy of growth factor receptors signaling downregulation for the suppression of liver fibrosis and cirrhosis and their individual manifestations.
...
1
2
3
4
...

References

SHOWING 1-10 OF 44 REFERENCES
Targeted inhibition of platelet-derived growth factor receptor-β subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats
TLDR
It is demonstrated that PDGFR-β siRNA may be presented as an antifibrogenic agent and the application of HSCs-specific RNA interference induced by the GFAP promoter might supply a new powerful tool for cell-specific gene therapy of hepatic fibrogenesis.
Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex
TLDR
It is shown that PDGFs share a conserved region in their prodomain sequences which can remain noncovalently associated with the mature cystine-knot growth factor domain after processing, and the structure of the PDGF-A/propeptide complex reveals this conserved, hydrophobic association mode.
Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
TLDR
Platelets produce PDGFB to activate HSC and promote fibrosis in MDR2-null mice and mice on DDC-supplemented diets, and MOR8457 produced a dose-dependent decrease in liver fibrosis and significantly reduced progression of fibrosis over 1 year.
Role of platelet-derived growth factors in physiology and medicine.
TLDR
Basic aspects of the PDGF ligands and receptors, their developmental and pathological functions, principles of their pharmacological inhibition, and results using PDGF pathway-inhibitory or stimulatory drugs in preclinical and clinical contexts are reviewed.
...
1
2
3
4
5
...